Background: In New Zealand, haemoglobin A1c measurements are routinely offered at booking, preferably before 20 weeks gestation, to detect pre-existing hyperglycaemia. A haemoglobin A1c <5.9% (41 mmol/mol) is considered normal based on the reference range for the non-pregnant population.
INTRODUCTION
In New Zealand it is recommended that all pregnant women are offered screening for pre-existing hyperglycaemia (diabetes and pre-diabetes) with a haemoglobin A1c (HbA1c) measurement at booking, preferably taken before 20 weeks gestation and the onset of pregnancy-induced insulin resistance. 1 The recommended HbA1c thresholds for intervention are: ≥6.7% (50 mmol/ mol) referral to diabetes clinic; 5.9-6.6% (41-49 mmol/mol) lifestyle advice and a subsequent 75 g glucose tolerance test (GTT) at 24 weeks gestation; ≤5.8% (40 mmol/mol) no early intervention and a subsequent gestational diabetes (GDM) screen between 24 and 28 weeks gestation. These HbA1c thresholds are derived from those used for the non-pregnant population and may not be appropriate for pregnancy. In one study, an early pregnancy HbA1c ≥6.5% (48 mmol/mol) missed half of those identified with type 2 diabetes by GTT criteria, whereas a HbA1c of ≥5.9%
(41 mmol/mol) was 100% sensitive. 2 This study also found that an early pregnancy HbA1c of 5.9-6.4% (41-46 mmol/mol) was associated with poorer pregnancy outcomes than a HbA1c of
≤5.8% (40 mmol/mol).
Previous studies examining antenatal HbA1c levels are not relevant to large-scale population screening since most excluded women with obesity and other risk factors for diabetes. [3] [4] [5] [6] [7] [8] [9] With the exception of a Japanese study, non-European women were not studied, although data from non-pregnant populations suggest that HbA1c levels may differ by ethnicity. [10] [11] [12] [13] Our aim was to establish antenatal HbA1c centiles by gestation and ethnicity that could subsequently be used to interpret HbA1c levels taken in early pregnancy. 
MATERIALS AND METHODS

Statistical analyses
All HbA1c tests that could be linked to an eligible pregnancy were included in the analysis. Mean HbA1c reference ranges were mod- and within-subject changes between first versus later trimesters tested against the null hypothesis of no difference using paired t-tests. Statistical analysis was performed using r 3.2.3 15 using the mgcv 16 package for construction of GAMs.
RESULTS
Data from 6800 pregnancies met our inclusion criteria. From an initial 13 998 pregnancies, we excluded 4426 with no matching HbA1c test, 2547 with no matching GDM screen, and 225 with a positive GDM screen (Table 1) . Pregnancies excluded with no matching screening tests were associated with younger maternal age and a higher proportion of Māori, whereas pregnancies excluded with a positive GDM screen were associated with older maternal age, a higher proportion of non-Europeans, and higher rates of induction of labour and caesarean section (P < 0.001 for all differences across the four groups). Table S1 shows the number of recorded HbA1c tests at each gestation by ethnicity; 380/6800 (5.6%) of pregnancies had more than one matching HbA1c test.
Pregnancies with multiple HbA1c tests were more likely to be to non-European mothers compared with pregnancies with only one
HbA1c test (European 71%, Māori 11%, Pacific 6%, Other 12% vs European 81%, Māori 6%, Pacific 3%, Other 11%, P < 0.001), and the mothers had marginally younger mean (interquartile range (IQR)) age 30 (25-34) versus 31 (27-35) years, P = 0.02, respectively.
In addition, pregnancies with multiple HbA1c tests compared with pregnancies with only one HbA1c test were less likely to have had a GCT (50% vs 72% respectively, P < 0.001), and more likely to have had a GTT test (57% vs 38%, respectively, P < 0.001). All glycaemic test results although normal, were marginally higher in the group that had more than one HbA1c test; GCT mean (IQR) 6.1 and greatest at the 97.5th.
We analysed the GCT and GTT results for pregnancies included in the study to see if differences in glycaemia, within the range considered normal, could explain the variability in inter-ethnic HbA1c levels. Estimated age-adjusted differences in glycaemic control, derived by linear regression ( Table 2 ), show that compared to Europeans, women of 'Other' ethnicity had higher plasma glucose levels post-glucose load, whereas Māori and Pacific women had higher fasting plasma glucose levels.
DISCUSSION
We examined HbA1c levels in a multi-ethnic group of pregnant women without diabetes, to establish gestation and ethnicityspecific HbA1c centiles. Beginning early in pregnancy, HbA1c levels were sequentially and significantly lower by gestational age reaching a nadir at 24 weeks gestation, both in the total population screened and verified by longitudinal data. Additionally, the longitudinal data showed a late pregnancy rise in HbA1c, with no difference seen between first and third-trimester HbA1c levels. Compared to European women, the mean HbA1c of non-Europeans was 0.1-0.2% (1-2 mmol/mol) higher throughout pregnancy. Glycaemic levels appeared to account for some of this variance, as non-European women had higher glucose levels, but within the range considered 'normal' in New Zealand, on GCT and GTT. We found that the New Zealand HbA1c cut-off ≥5.9% (≥41 mmol/mol) for screening, was greater than the 97.5th centile for all non-Māori and non-Pacific women.
We produced novel antenatal HbA1c centile charts adjusted by gestational week and we are the first to examine inter-ethnic variability in antenatal HbA1c levels. In contrast to others, we included women irrespective of their BMI and risk factors for GDM; our results may thus be more widely applicable. Our findings concur with those of others, in that HbA1c levels were lower in the second versus the first-trimester. [3] [4] [5] [6] [7] [8] [9] Most pregnancies in our study and other studies had only one corresponding HbA1c test; however, the longitudinal data verified the dynamic trend in HbA1c levels by gestation seen in the total population screened. This is likely to be a result of both a decrease in fasting blood glucose levels and increased red cell production in early pregnancy. 17 Our 97.5th centiles for HbA1c in European women are similar to those reported by some 8, 9 including the HAPO study group, 18 but exceed those reported by others that range from 4.9 to 5.7% (30-39 mmol/mol) 3-7 in the first 
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However, iron deficiency is more prevalent after 20 weeks gestation and less likely to impact on early pregnancy screening. Further studies could examine whether factors other than glycaemia influence HbA1c levels in different ethnic groups, such as the prevalence of factors affecting red cell turnover or genetic glycation differences, or whether HbA1c is truly a better marker of glycaemic status than a GTT in some.
In conclusion, we found that the New Zealand antenatal
HbA1c threshold for early intervention exceeds the 97.5th centile in European women and 'others' of largely Asian descent. It seems sensible therefore to utilise pregnancy-specific HbA1c centiles, which may better inform management decisions.
F I G U R E 2
Change in mean haemoglobin A1c levels by trimester of pregnancy using longitudinally collected data. Data presented as mean HbA1c with confidence intervals, taken from women who had ≥2 HbA1c measurements in pregnancy. 
